XPC deficiency leads to centrosome amplification by inhibiting BRCA1 expression upon cisplatin-mediated DNA damage in human bladder cancer
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 444, 136-146
Abstract
No abstract availableKeywords
Funding Information
- National Nature Science Foundation of China (30972979, 81372726, 81272822)
This publication has 46 references indexed in Scilit:
- Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasisJournal of Clinical Investigation, 2010
- A Centrosome-autonomous Signal That Involves Centriole Disengagement Permits Centrosome Duplication in G2 Phase after DNA DamageMolecular Biology of the Cell, 2010
- Coordination of Centrosome Homeostasis and DNA Repair Is Intact in MCF-7 and Disrupted in MDA-MB 231 Breast Cancer CellsCancer Research, 2010
- Mechanism of Replication-Coupled DNA Interstrand Crosslink RepairCell, 2008
- Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patientsOncogene, 2008
- Attenuated Expression of Xeroderma Pigmentosum Group C Is Associated with Critical Events in Human Bladder Cancer Carcinogenesis and ProgressionCancer Research, 2007
- Long-term XPC Silencing Reduces DNA Double-Strand Break RepairCancer Research, 2007
- 2-AAF-induced tumor development in nucleotide excision repair-deficient mice is associated with a defect in global genome repair but not with transcription coupled repairDNA Repair, 2005
- Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell linesInternational Journal of Cancer, 2004
- Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpressionOncogene, 2000